Guo Wei, Geng Jialu, Li Dongmei
Beijing Tongren Eye Center, and Beijing Ophthalmology Visual Science Key Lab, Beijing Tongren Hospital, Capital Medical University, No.1 Dong Jiao Min Xiang, Beijing, 100730, China.
BMC Ophthalmol. 2024 Dec 18;24(1):526. doi: 10.1186/s12886-024-03749-3.
In thyroid-associated ophthalmopathy (TAO), orbital decompression is a critical surgical approach for functional and aesthetic reasons. Meanwhile, the presence of surgical complications, especially the new onset of primary gaze diplopia, also influences postoperative patient satisfaction. This research investigates the effectiveness and potential risks associated with different orbital decompression in patients with TAO.
Systematic searches were conducted to identify pertinent studies from PubMed, Embase, and the Cochrane Library databases. The search was completed on October 11, 2023. And after retrieval, the publication dates of the articles included in the analysis ranged from January 1, 2008, to February 22, 2023. The overall postoperative outcomes were determined using random-effects meta-analyses with corresponding 95% confidence intervals (CI). A network meta-analysis was performed to integrate both direct and indirect evidence. The primary outcomes were defined as the status of exophthalmos and the new onset of primary gaze diplopia.
From 1,538 identified records, 87 studies were selected, encompassing 5102 patients and 8,779 procedures. The studies reported varying degrees of exophthalmos reduction based on different surgical techniques: -3.46 mm (95% CI -3.76 to -3.15 mm) for fat removal orbital decompression, -4.02 mm (95% CI -5.14 to -2.89 mm) for the medial wall technique, -3.89 mm (95% CI -4.22 to -3.55 mm) for the lateral wall technique, -5.23 mm (95% CI -5.69 to -4.77 mm) for the balanced wall technique, -3.91 mm (95% CI -4.37 to -3.46 mm) for the infero-medial wall technique, and - 5.80 mm (95% CI -6.47 to -5.13 mm) for the three-wall technique. The incidence of new-onset primary gaze diplopia was reported in 31 studies involving 214 out of 2001 patients, resulting in a weighted proportion of 0.11 (95% CI 0.06-0.14). Notably, the lowest rates were associated with the lateral approach and fat removal orbital decompression, with pooled proportion (95% CI) rates of 3% (1-6) and 3% (2-4), respectively, suggesting that these two techniques may be more effective in preventing the occurrence of this complication during the postoperative period.
This meta-analysis establishes that orbital decompression is a beneficial and safe surgical approach. While this study enhances the evidence hierarchy for orbital decompression in treating TAO, it requires further validation through larger, prospective, and randomized studies with long-term follow-up periods.
在甲状腺相关眼病(TAO)中,出于功能和美观的原因,眼眶减压是一种关键的手术方法。同时,手术并发症的出现,尤其是原发性凝视复视的新发,也会影响术后患者的满意度。本研究调查了TAO患者不同眼眶减压方法的有效性和潜在风险。
进行系统检索以识别来自PubMed、Embase和Cochrane图书馆数据库的相关研究。检索于2023年10月11日完成。检索后,纳入分析的文章发表日期从2008年1月1日至2023年2月22日。使用随机效应荟萃分析及相应的95%置信区间(CI)确定总体术后结果。进行网络荟萃分析以整合直接和间接证据。主要结局定义为眼球突出状态和原发性凝视复视的新发情况。
从1538条识别记录中,选择了87项研究,涵盖5102例患者和8779例手术。研究报告了基于不同手术技术的不同程度的眼球突出减少情况:脂肪去除眼眶减压为-3.46mm(95%CI -3.76至-3.15mm),内侧壁技术为-4.02mm(95%CI -5.14至-2.89mm),外侧壁技术为-3.89mm(95%CI -4.22至-3.55mm),平衡壁技术为-5.23mm(95%CI -5.69至-4.77mm),下内侧壁技术为-3.91mm(95%CI -4.37至-3.46mm),三壁技术为-5.80mm(95%CI -6.47至-5.13mm)。31项研究报告了2001例患者中214例原发性凝视复视的新发情况,加权比例为0.11(95%CI 0.06 - 0.14)。值得注意的是,最低发生率与外侧入路和脂肪去除眼眶减压相关,合并比例(95%CI)率分别为3%(1 - 6)和3%(2 - 4),表明这两种技术在预防术后该并发症的发生方面可能更有效。
这项荟萃分析证实眼眶减压是一种有益且安全的手术方法。虽然本研究提高了眼眶减压治疗TAO的证据等级,但仍需要通过更大规模、前瞻性、长期随访的随机研究进行进一步验证。